1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) AI in Drug Discovery Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) AI in Drug Discovery Market - Industry Life Cycle |
3.4 United Kingdom (UK) AI in Drug Discovery Market - Porter's Five Forces |
3.5 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume Share, By Technology, 2022 & 2032F |
4 United Kingdom (UK) AI in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions |
4.2.2 Growing adoption of AI and machine learning technologies in healthcare |
4.2.3 Rising investments in AI research and development in the UK |
4.3 Market Restraints |
4.3.1 High initial investment costs for integrating AI in drug discovery processes |
4.3.2 Data privacy and security concerns related to AI applications in healthcare |
5 United Kingdom (UK) AI in Drug Discovery Market Trends |
6 United Kingdom (UK) AI in Drug Discovery Market, By Types |
6.1 United Kingdom (UK) AI in Drug Discovery Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Drug Type, 2022-2032F |
6.1.3 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Large molecules, 2022-2032F |
6.1.4 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Small molecules, 2022-2032F |
6.2 United Kingdom (UK) AI in Drug Discovery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.3 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Infectious diseases, 2022-2032F |
6.2.4 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Neurological disorders, 2022-2032F |
6.2.5 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Rare diseases, 2022-2032F |
6.2.6 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Metabolic diseases, 2022-2032F |
6.2.7 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Cardiovascular diseases, 2022-2032F |
6.3 United Kingdom (UK) AI in Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Pharmaceutical & biotechnology companies, 2022-2032F |
6.3.3 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Contract research organizations, 2022-2032F |
6.3.4 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Academics & research, 2022-2032F |
6.3.5 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Others, 2022-2032F |
6.4 United Kingdom (UK) AI in Drug Discovery Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Machine learning, 2022-2032F |
6.4.3 United Kingdom (UK) AI in Drug Discovery Market Revenues & Volume, By Others, 2022-2032F |
7 United Kingdom (UK) AI in Drug Discovery Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) AI in Drug Discovery Market Export to Major Countries |
7.2 United Kingdom (UK) AI in Drug Discovery Market Imports from Major Countries |
8 United Kingdom (UK) AI in Drug Discovery Market Key Performance Indicators |
8.1 Number of successful AI-driven drug discovery projects in the UK |
8.2 Increase in partnerships between pharmaceutical companies and AI technology providers |
8.3 Growth in the number of AI talent and research centers focusing on drug discovery in the UK |
9 United Kingdom (UK) AI in Drug Discovery Market - Opportunity Assessment |
9.1 United Kingdom (UK) AI in Drug Discovery Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 United Kingdom (UK) AI in Drug Discovery Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United Kingdom (UK) AI in Drug Discovery Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 United Kingdom (UK) AI in Drug Discovery Market Opportunity Assessment, By Technology, 2022 & 2032F |
10 United Kingdom (UK) AI in Drug Discovery Market - Competitive Landscape |
10.1 United Kingdom (UK) AI in Drug Discovery Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) AI in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |